Diagnostic criteria and laboratory tests for disseminated intravascular coagulation

Toshihiro Kaneko1, Hideo Wada

  • 1Department of Patient Safety and Infectinon Control, Mie University Graduate School of Medicine, Tsu, Japan.

Insights

Disseminated intravascular coagulation (DIC) is a fatal condition often linked to organ failure. Early diagnosis and treatment using hemostatic markers are crucial for improving patient outcomes.

Area of Science:

  • Hematology
  • Critical Care Medicine

Background:

  • Disseminated intravascular coagulation (DIC) is a life-threatening condition associated with organ failure, frequently stemming from infections, hematological malignancies, or solid cancers.
  • DIC presents in two forms: overt and non-overt.
  • Established diagnostic criteria by the International Society on Thrombosis and Haemostasis (ISTH) and the Japanese Association for Acute Medicine (JAAM) aim to standardize diagnosis.

Purpose of the Study:

  • To review the current understanding of Disseminated Intravascular Coagulation (DIC) diagnosis and treatment.
  • To highlight the importance of early detection and intervention in managing DIC.
  • To discuss potential therapeutic advancements for improving DIC mortality rates.

Main Methods:

  • Review of existing literature on DIC diagnostic criteria, including ISTH and JAAM guidelines.
  • Analysis of the mechanisms underlying DIC development, focusing on factors like tissue factor and cytokines.
  • Examination of current and emerging treatment strategies, including novel therapeutic agents.

Main Results:

  • The JAAM diagnostic criteria show high sensitivity for predicting mortality in DIC but lack specificity.
  • Mechanisms of DIC onset are diverse, influenced by underlying pathologies and biological factors.
  • Hemostatic molecular markers are essential for early and accurate DIC diagnosis.

Conclusions:

  • Early diagnosis and prompt treatment are critical for improving outcomes in patients with DIC.
  • Emerging therapies such as recombinant activated protein C and recombinant thrombomodulin show promise in reducing DIC mortality.
  • Further research is necessary to develop improved diagnostic and therapeutic approaches for DIC.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...